Danuta J. Herzyk

Immunogenicity of biologically-derived therapeutics: Assessment and interpretation of nonclinical safety studies

Rafael Ponce, Leslie W. Abad, Lakshmi Amaravadi et al. · Regulatory Toxicology and Pharmacology · 2009 · 268 citations

Pharmacy, Immunology, Pharmacokinetics +14

Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys

Timothy K. Hart, Richard M. Cook, Parnian Zia‐Amirhosseini et al. · Journal of Allergy and Clinical Immunology · 2001 · 241 citations · Full text

Medicine, Immunology, Pharmacology +16

Primary antibody response to keyhole limpet hemocyanin in rat as a model for immunotoxicity evaluation

Elizabeth R. Gore, Jill Gower, Edit Kurali et al. · Toxicology · 2004 · 72 citations

Pharmacy, Immunology, Toxicology +5

Characterization of MK-4166, a Clinical Agonistic Antibody That Targets Human GITR and Inhibits the Generation and Suppressive Effects of T Regulatory Cells

Selvakumar Sukumar, Douglas C. Wilson, Ying Yu et al. · Cancer Research · 2017 · 63 citations

Life Sciences, Immunology, Oncology +17

Sandwich ELISA formats designed to detect 17 kDa IL-1β significantly underestimate 35 kDa IL-1β

Danuta J. Herzyk, Ann E. Berger, James N. Allen et al. · Journal of Immunological Methods · 1992 · 58 citations

Life Sciences, Immunology, Molecular Biology +10